Your browser doesn't support javascript.
loading
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer Properties.
Krastel, Philipp; Roggo, Silvio; Schirle, Markus; Ross, Nathan T; Perruccio, Francesca; Aspesi, Peter; Aust, Thomas; Buntin, Kathrin; Estoppey, David; Liechty, Brigitta; Mapa, Felipa; Memmert, Klaus; Miller, Howard; Pan, Xuewen; Riedl, Ralph; Thibaut, Christian; Thomas, Jason; Wagner, Trixie; Weber, Eric; Xie, Xiaobing; Schmitt, Esther K; Hoepfner, Dominic.
Afiliação
  • Krastel P; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Roggo S; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Schirle M; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Ross NT; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Perruccio F; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Aspesi P; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Aust T; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Buntin K; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Estoppey D; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Liechty B; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Mapa F; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Memmert K; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Miller H; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Pan X; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Riedl R; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Thibaut C; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Thomas J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139 (USA).
  • Wagner T; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Weber E; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Xie X; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Schmitt EK; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland).
  • Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Campus, 4056 Basel (Switzerland). dominic.hoepfner@novartis.com.
Angew Chem Int Ed Engl ; 54(35): 10149-54, 2015 Aug 24.
Article em En | MEDLINE | ID: mdl-26179970
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Myxococcales / Fator 1 de Elongação de Peptídeos / Compostos Macrocíclicos / Proliferação de Células / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Myxococcales / Fator 1 de Elongação de Peptídeos / Compostos Macrocíclicos / Proliferação de Células / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2015 Tipo de documento: Article